C(2022) 5938 final
Version milestone
Publication Date
Aug 22, 2022
Effective Date
Aug 22, 2022
The manufacture of sterile products covers a wide range of sterile product types (active substance, excipient, primary packaging material and finished dosage form), packed sizes (single unit to multiple units), processes (from highly automated systems to manual processes) and technologies (e.g. biotechnology, classical small molecule manufacturing systems and closed systems). This Annex provides general guidance that should be used in the design and control of facilities, equipment, systems and procedures used for the manufacture of all sterile products applying the principles of Quality Risk Management (QRM), to ensure that microbial, particulate and endotoxin/pyrogen contamination is prevented in the final product.
Chronological release history
Version milestone
Publication Date
Aug 22, 2022
Effective Date
Aug 22, 2022
We use cookies to improve your experience, analyze website usage, and show you relevant information. By accepting all cookies, you help us improve the website. View our privacy statement.
Necessary
Always active. Required for the website to function properly.
Statistics
Helps us improve the website through anonymous statistics.
Marketing
For third-party marketing and tracking cookies.